Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 3Plasma cell 1Myeloid 1Classical hematology 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 235Lymphoma 160Leukemia 109Burkitt Lymphoma 91Lymphoma, Non-Hodgkin 85Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Mantle-Cell 70Leukemia, Myeloid, Acute 53Lymphoma, Follicular 49Hodgkin Disease 44Lymphoma, Large-Cell, Immunoblastic 37Leukemia, Lymphocytic, Chronic, B-Cell 33Recurrence 32Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, B-Cell, Marginal Zone 24Leukemia, Biphenotypic, Acute 24Myelodysplastic Syndromes 23Blast Crisis 19Lymphoma, Large-Cell, Anaplastic 18Lymphoma, B-Cell 18Dendritic Cell Sarcoma, Interdigitating 17Congenital Abnormalities 17Leukemia, Myeloid, Accelerated Phase 16Leukemia, Myelomonocytic, Chronic 15Multiple Myeloma 12Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, T-Cell 11Myeloproliferative Disorders 10Anemia, Refractory, with Excess of Blasts 10Neoplasms, Plasma Cell 9

Interventions

Cyclophosphamide 5Etoposide 4Cytarabine 3sargramostim 2denileukin diftitox 2Radiotherapy 2Filgrastim 2Dexamethasone 2Carboplatin 2Amifostine 2sodium thiosulfate 1pegfilgrastim 1pegaspargase 1glucarpidase 1etoposide phosphate 1Vincristine 1Silymarin 1Rituximab 1Prednisolone 1Phenobarbital 1Methylprednisolone 1Methotrexate 1Mercaptopurine 1Leucovorin 1Irinotecan 1Ifosfamide 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Fibroblast Growth Factor 7 1Epoetin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Cytarabine × Lymphoid × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00002818 2015-12-14

High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

Virginia Commonwealth University

Phase 1 Completed
15 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡